Details of the Drug Reposition

General Information of This Drug (ID: DMQW7LR)

• Drug Name: ACT-101 (DMQW7LR)

Information on Drug Reposition of This Drug

2 Phase 1 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Multiple sclerosis	DISB2WZI	8A40	Phase 1	[1]
Myasthenia gravis	DISELRCI	8C6Y	Phase 1	[1]

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)